Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
TETRACAINE HYDROCHLORIDE
Smith & Nephew Healthcare Limited
N01BA03
TETRACAINE HYDROCHLORIDE
40 mg/g
Gel
Product not subject to medical prescription
Esters of aminobenzoic acid
Transfer Pending
1996-05-21
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ametop 40 mg/g Gel. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram of gel contains 40 mg tetracaine (as hydrochloride) equivalent to tetracaine base 4.0% w/w. Excipients: For full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Gel White, opalescent gel. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Percutaneous local anaesthetic to produce anaesthesia of the skin prior to venepuncture, venous cannulation or non- ablative dermal laser procedures. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults (including the elderly) and children over 1 month of age: Apply the contents of the tube to the centre of the area to be anaesthetised and cover with an occlusive dressing. The contents expellable from 1 tube (approximately 1 gram) are sufficient to cover and anaesthetise an area of up to 30 sq.cm. (6x5cm). Smaller areas of anaesthetised skin may be adequate in infants and small children. Adequate anaesthesia can usually be achieved following a thirty minute application time for venepuncture, and a forty- five minute application time for venous cannulation and an application time of one to two hours for laser procedures, after which the gel should be removed with a gauze swab and the site prepared with an antiseptic wipe in the normal manner. Up to five tubes of Ametop Gel can be applied for dermal laser procedures, however no more than one tube should be applied to children under 5 years of age. Application of Ametop Gel can be repeated after a maximum of 5 hours if necessary. The maximum cumulative dose in a 24 hour period should not exceed 7 tubes for adults and 2 tubes for children. Not recommended for infants under 1 month of age. Sodium methyl parahydroxbenzoate (E219) 2 mg/ Read the complete document